As of January 22, 2025, MaxCyte (MXCT) has a market cap of $0.53 billion USD. According to our data, MaxCyte is ranked No.6035 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.53 B |
21.63%
|
Dec 31, 2024 | $0.44 B |
-11.49%
|
Dec 29, 2023 | $0.50 B |
-13.92%
|
Dec 30, 2022 | $0.58 B |
-46.42%
|
Dec 31, 2021 | $1.07 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Danaher
DHR
|
$176.37 B |
0.003 M
|
USA
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Becton Dickinson
BDX
|
$69.00 B |
-0.002 M
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
Charles River Laboratories
CRL
|
$8.60 B |
-0.000 M
|
USA
|
Bruker
BRKR
|
$9.11 B |
0.000 M
|
USA
|
Waters Corporation
WAT
|
$24.25 B |
0.000 M
|
USA
|
Bio-Techne
TECH
|
$12.51 B |
0.000 M
|
USA
|
Market Cap | = | MXCT Stock Price | * | MXCT Shares Outstanding |
= | $5.06 | * | 0.11 B | |
= | $0.53 B |